{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:22:59Z","timestamp":1791559379668,"version":"4.3.4"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,18]]},"DOI":"10.7759\/cureus.114716","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T10:33:16Z","timestamp":1787049196000},"source":"Crossref","is-referenced-by-count":1,"title":["Haemorrhagic Occlusive Retinal Vasculitis Following Cataract Surgery Without Intraocular Vancomycin"],"prefix":"10.7759","author":[{"given":"Sarah","family":"Grech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Bezzina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Calleja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.11.042","article-title":"Vancomycin-associated hemorrhagic occlusive retinal vasculitis clinical characteristics of 36 eyes","volume":"124","author":"Witkin AJ","year":"2017","unstructured":"Witkin AJ, Chang DF, Jumper JM, et al.. Vancomycin-associated hemorrhagic occlusive retinal vasculitis clinical characteristics of 36 eyes. Ophthalmology. 2017, 124:583-95. 10.1016\/j.ophtha.2016.11.042","journal-title":"Ophthalmology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/24741264251332515","article-title":"Intraocular inflammation, safety events, and outcomes after intravitreal injection of ranibizumab, aflibercept, brolucizumab, abicipar pegol, and faricimab for nAMD","volume":"9","author":"Stevanovic M","year":"2025","unstructured":"Stevanovic M, Koulisis N, Chen T, et al.. Intraocular inflammation, safety events, and outcomes after intravitreal injection of ranibizumab, aflibercept, brolucizumab, abicipar pegol, and faricimab for nAMD. J Vitreoretin Dis. 2025, 9:406-15. 10.1177\/24741264251332515","journal-title":"J Vitreoretin Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2006.02.021","article-title":"ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study","volume":"32","author":"Barry P","year":"2006","unstructured":"Barry P, Seal DV, Gettinby G, Lees F, Peterson M, Revie CW. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study. J Cataract Refract Surg. 2006, 32:407-10. 10.1016\/j.jcrs.2006.02.021","journal-title":"J Cataract Refract Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.14175","article-title":"The standardisation of uveitis nomenclature (SUN) project","author":"Jabs DA","year":"2022","unstructured":"Jabs DA, McCluskey P, Palestine AG, Thorne JE. The standardisation of uveitis nomenclature (SUN) project. Clin Exp Ophthalmol. 2022, 10.1111\/ceo.14175","journal-title":"Clin Exp Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2018.01.030","article-title":"Vancomycin-associated hemorrhagic occlusive retinal vasculitis: a clinical-pathophysiological analysis","volume":"188","author":"Todorich B","year":"2018","unstructured":"Todorich B, Faia LJ, Thanos A, et al.. Vancomycin-associated hemorrhagic occlusive retinal vasculitis: a clinical-pathophysiological analysis. Am J Ophthalmol. 2018, 188:131-40. 10.1016\/j.ajo.2018.01.030","journal-title":"Am J Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2022.4697","article-title":"Hemorrhagic occlusive retinal vasculitis associated with triamcinolone-moxifloxacin use during uncomplicated cataract surgery","volume":"141","author":"Pan WW","year":"2022","unstructured":"Pan WW, Miller AR, Young BK, Johnson MW, Sassalos TM. Hemorrhagic occlusive retinal vasculitis associated with triamcinolone-moxifloxacin use during uncomplicated cataract surgery. JAMA Ophthalmol. 2022, 141:99-101. 10.1001\/jamaophthalmol.2022.4697","journal-title":"JAMA Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3928\/23258160-20221026-03","article-title":"Vancomycin-associated hemorrhagic occlusive retinal vasculitis: a case series and systematic review","volume":"53","author":"Matovi\u0107 K","year":"2022","unstructured":"Matovi\u0107 K, Mekjavi\u0107 PJ, Groznik AL, Fakin A, Petrovi\u010d MG, Pfeifer V, Valentin\u010di\u010d NV. Vancomycin-associated hemorrhagic occlusive retinal vasculitis: a case series and systematic review. Ophthalmic Surg Lasers Imaging Retina. 2022, 53:702-12. 10.3928\/23258160-20221026-03","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/ICB.0000000000000389","article-title":"Hemorrhagic occlusive retinal vasculitis and nonhemorrhagic vasculitis after uncomplicated cataract surgery with intracameral vancomycin","volume":"11 Suppl 1","author":"Ehmann DS","year":"2017","unstructured":"Ehmann DS, Adam MK, Kasi SK, Sivalingam A, Dunn JP. Hemorrhagic occlusive retinal vasculitis and nonhemorrhagic vasculitis after uncomplicated cataract surgery with intracameral vancomycin. Retin Cases Brief Rep. 2017, 11 Suppl 1:S155-8. 10.1097\/ICB.0000000000000389","journal-title":"Retin Cases Brief Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.03.016","article-title":"Postoperative hemorrhagic occlusive retinal vasculitis: expanding the clinical spectrum and possible association with vancomycin","volume":"122","author":"Witkin AJ","year":"2015","unstructured":"Witkin AJ, Shah AR, Engstrom RE, et al.. Postoperative hemorrhagic occlusive retinal vasculitis: expanding the clinical spectrum and possible association with vancomycin. Ophthalmology. 2015, 122:1438-51. 10.1016\/j.ophtha.2015.03.016","journal-title":"Ophthalmology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-017-0632-y","article-title":"Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery","volume":"17","author":"Andreanos K","year":"2017","unstructured":"Andreanos K, Petrou P, Kymionis G, Papaconstantinou D, Georgalas I. Early anti-VEGF treatment for hemorrhagic occlusive retinal vasculitis as a complication of cataract surgery. BMC Ophthalmol. 2017, 17:238. 10.1186\/s12886-017-0632-y","journal-title":"BMC Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/513815-haemorrhagic-occlusive-retinal-vasculitis-following-cataract-surgery-without-intraocular-vancomycin","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T10:33:17Z","timestamp":1787049197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/513815-haemorrhagic-occlusive-retinal-vasculitis-following-cataract-surgery-without-intraocular-vancomycin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.114716","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,18]]}}}